AJP - Regu Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 288: R322-R328, 2005. First published September 23, 2004; doi:10.1152/ajpregu.00509.2004
0363-6119/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/R322    most recent
00509.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogzil, A. H.
Right arrow Articles by Ashton, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogzil, A. H.
Right arrow Articles by Ashton, N.

WATER AND ELECTROLYTE HOMEOSTASIS

Relaxin-induced changes in renal sodium excretion in the anesthetized male rat

Alsadek H. Bogzil, Rachel Eardley, and Nick Ashton

School of Biological Sciences, University of Manchester, Manchester, United Kingdom

Submitted 28 July 2004 ; accepted in final form 22 September 2004

Pregnancy is associated with profound changes in renal hemodynamics and electrolyte handling. Relaxin, a hormone secreted by the corpus luteum, has been shown to induce pregnancy-like increases in renal blood flow and glomerular filtration rate (GFR) and alter osmoregulation in nonpregnant female and male rats. However, its effects on renal electrolyte handling are unknown. Accordingly, the influence of short (2 h)- and long-term (7 day) infusion of relaxin on renal function was determined in the male rat. Short term infusion of recombinant human relaxin (rhRLX) at 4 µg·h–1·100 g body wt–1 induced a significant increase in effective renal blood flow (ERBF) within 45 min, which peaked at 2 h of infusion (vehicle, n = 6, 2.1 ± 0.4 vs. rhRLX, n = 7, 8.1 ± 1.1 ml·min–1·100 g body wt–1, P < 0.01). GFR and urinary excretion of electrolytes were unaffected. After a 7-day infusion of rhRLX at 4 µg/h, ERBF (1.4 ± 0.2 vs. 2.5 ± 0.4 ml·min–1·100 g body wt–1, P < 0.05), urine flow rate (3.1 ± 0.3 vs. 4.3 ± 0.4 µl·min–1·100 g body wt–1, P < 0.05) and urinary sodium excretion (0.8 ± 0.1 vs. 1.2 ± 0.1 µmol·min–1·100 g body wt–1, P < 0.05) were significantly higher; plasma osmolality and sodium concentrations were lower in rhRLX-treated rats. These data show that long-term relaxin infusion induces a natriuresis and diuresis in the male rat. The mechanisms involved are unclear, but they do not involve changes in plasma aldosterone or atrial natriuretic peptide concentrations.

relaxin; kidney; renal blood flow; aldosterone; atrial natriuretic peptide



Address for reprint requests and other correspondence: N. Ashton, School of Biological Sciences, Univ. of Manchester, G.38 Stopford Bldg., Oxford Rd., Manchester M13 9PT, UK (E-mail: nick.ashton{at}man.ac.uk)




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. C. Smith, Lee. A. Danielson, Kirk. P. Conrad, and J. M. Davison
Influence of Recombinant Human Relaxin on Renal Hemodynamics in Healthy Volunteers
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3192 - 3197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.